Helix ResearchOne of the largest gene-based collapsing analyses reveals potential candidate genes for population screeningAugust 3, 2021
Population GenomicsThe Incrementalist: Genetic Screening for the Whole Population with James Lu MD PhDMay 28, 2021
Company NewsMarc Stapley Assumes Role of Executive Chairman of the Board of Directors of Helix; President and Co-founder James Lu Appointed President and Chief Executive OfficerMay 6, 2021
Helix PartnersComprehensive allele genotyping in critical pharmacogenes reduces residual clinical risk in diverse populationsApril 30, 2021
Helix PartnersPathogenic variants in actionable MODY genes are associated with type 2 diabetesOctober 11, 2020
Helix PartnersMayo Clinic to sequence 100K participants to build genomic database for improved care and research in collaboration with HelixJanuary 9, 2020
Helix PartnersMayo Clinic to Sequence 100,000 Participants to Build Genomic Database for Improved Care and Research in Collaboration with HelixJanuary 9, 2020
Population GenomicsA comprehensive landscape of CYP2D6 variation across 30,000 individualsOctober 17, 2019
Helix PartnersApplying Confidence Intervals to Clinical Polygenic Risk Scores in 60,000 Exome+ Sequenced IndividualsOctober 17, 2019
Helix PartnersA genetic retrospective study of Maturity-Onset Diabetes of the Young (MODY) in two population health studiesOctober 16, 2019
Helix PartnersThe spectrum of mitochondrial genomic variation across 250,000 individualsOctober 16, 2019
Health SystemsFirst-line preventative genetic screening: Disease penetrance in Tier 1 inherited diseases in an all-comers population is similar to family history selected populationsOctober 16, 2019
Helix PartnersPopulation Health Study Goes Statewide As University Medical Center of Southern Nevada Serves As Host Site For Enrollment Of 25,000 More NevadansMay 7, 2019
Health SystemsGenetic counseling, 2030: An on‐demand service tailored to the needs of a price conscious, genetically literate, and busy worldMarch 8, 2019
